Losses
-€132,234 in three years
Every financial year from 2023 to 2025 closed with a loss. 2025 was the heaviest.
FIGA MEDICALE
Lifetime
16 annual accounts with figures on one time axisGross marginpeak €55,713 (2012)
-€26,455▲ €12,108
Resultlowest -€58,053 (2021)
-€47,451▼ €8,916
Equitypeak €250,446 (2022)
€118,213▼ 28.6%
Debts
€21,365▲ 154%
Board1 name since 2003
1 directorFIGA Béatrice
Documentsfilings and deeds
10-10-202540 days late
2025micro format
Gross margin from -€38,563 to -€26,455Loss of €47,451Equity from €165,664 to €118,213Debts from €8,409 to €21,365Cash from €59,666 to €114,757
Key points
from the 2025 annual accountsPayment terms
48 days to suppliers
FIGA MEDICALE pays its suppliers 20 days later than in 2024. Customers pay 480 days earlier.
Filings
16 annual accounts 67 days past the deadline
2026 accounts not filed: deadline was 31-08-2026.
Checked score
54
Fair
Financially stronger than 48% of micro companies without a NACE code
Probability in this band: 1.5% to 4.2%
Bankruptcy probability within 12 months
1.9% Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 3.2%highest value
01-2025: 1.4%▼ -1.8 percentage points vs 12-2024
02-2025: 1.5%▲ +0.1 percentage points vs 01-2025
03-2025: 1.5%● unchanged vs 02-2025
04-2025: 1.5%● unchanged vs 03-2025
05-2025: 1.5%● unchanged vs 04-2025
06-2025: 1.5%● unchanged vs 05-2025
07-2025: 1.5%● unchanged vs 06-2025
08-2025: 1.5%● unchanged vs 07-2025
09-2025: 1.6%▲ +0.1 percentage points vs 08-2025
10-2025: 1.7%▲ +0.1 percentage points vs 09-2025
11-2025: 1.1%▼ -0.6 percentage points vs 10-2025lowest value
12-2025: 1.1%● unchanged vs 11-2025lowest value
01-2026: 1.1%● unchanged vs 12-2025
02-2026: 1.2%▲ +0.1 percentage points vs 01-2026
03-2026: 1.2%● unchanged vs 02-2026
04-2026: 1.2%● unchanged vs 03-2026
05-2026: 1.2%● unchanged vs 04-2026
06-2026: 1.2%● unchanged vs 05-2026
07-2026: 1.2%● unchanged vs 06-2026
08-2026: 1.2%● unchanged vs 07-2026
09-2026: 1.3%▲ +0.1 percentage points vs 08-2026
10-2026: 1.6%▲ +0.3 percentage points vs 09-2026
11-2026: 1.9%▲ +0.3 percentage points vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
No main activity registered
lowers risk
Size: turnover €55,134, total assets €139,578
Liquidity: current ratio 6.43, cash €114,757
Founded in 2008
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 87% on liquidity, 4% on profitability and 19% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-01-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 4,805 companies had the same profile as FIGA MEDICALE has now. Each dot stands for 13 companies, two years later.
88.1%
were still trading
9.8%
stopped another way
2.0%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of FIGA MEDICALE itself: 1.9% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 4,805 companies, not a prediction for FIGA MEDICALE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity is ample, with a current ratio of 6.43 (19.88 in 2024), above the usual 1.5. Short-term debt is 15.3% and cash 82.2% of total assets. 15.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Eight signals.
lowers riskraises risk
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
192122232425
2019 to 2025 · latest year -€47,451
raises risk · Annual accounts not filed
The financial year that closed on 31-01-2026 was due at the National Bank by 31-08-2026. Nothing is on record, 67 days later.
NBB · 10 filingsPosition against the passed deadline
31-01-2026 year end31-08-2026 deadline06-11-2026 today
raises risk · 2025 accounts filed 40 days late
The financial year that closed on 31-01-2025 was due by 31-08-2025 and was filed on 10-10-2025, 40 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2026
not filed
2025
40 days late
2024
101 days late
2023
110 days late
2022
512 days late
2021
877 days late
2019
89 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 6 accounts on average 288 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
raises risk · Administrative warnings in the KBO publications
The FPS Economy published 1 notice about the company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publicationsPublications
Strikeout withdrawn
Recent changes
Strikeout withdrawn
effective 25-01-2024 · KBO administration
Incorporation
published on 18-07-2008 · Gazette deed
Official details
Source: KBO- Status
- Active since 09-07-2008Normal situation
- Activity
- No activity registered in the KBO
- Financial year end
- 31 January
- Peppol
- Not found in the Peppol Directory
Insights on FIGA MEDICALE
FIGA MEDICALE files the micro format. That format states no turnover. The gross margin fell from €12,719 in 2009 to -€26,455 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FIGA MEDICALE
- What is the company number of FIGA MEDICALE?
- The company number of FIGA MEDICALE is 0899.145.557. The VAT number is the same number with BE in front: BE 0899.145.557.
- Where is FIGA MEDICALE based?
- The registered office is at Edmond Machtenslaan 63, 1080 Molenbeek-Saint-Jean.Company details
- What is the legal form of FIGA MEDICALE?
- FIGA MEDICALE is a private limited company (pre-2019) (BVBA).
- When was FIGA MEDICALE founded?
- FIGA MEDICALE was founded on 09-07-2008.
- Is FIGA MEDICALE still active?
- Yes, FIGA MEDICALE is an active enterprise in the KBO register.
- What is the turnover of FIGA MEDICALE?
- The turnover of FIGA MEDICALE was €55,134 in financial year 2025, according to the filed annual accounts.Financials
- Is FIGA MEDICALE profitable?
- In financial year 2025, FIGA MEDICALE made a loss of €47,451.
- Where can I find the annual accounts of FIGA MEDICALE?
- FIGA MEDICALE filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.